Cannabis Regulations Harmonization Amendments

Summary#

This is a proposed set of changes to the Cannabis Regulations published by the Department of Health on June 1, 2024. The changes aim to align the cannabis rules with parts of the Controlled Substances Regulations and add clearer rules about things like destruction, record‑keeping, test kits and traveller imports. This is a proposal (Part I); the government is asking for feedback within 60 days and, if adopted, the rules would come into force on the 365th day after they are published in Canada Gazette, Part II.

What it does#

• Aligns wording and definitions between the Cannabis Regulations and the Controlled Substances Regulations (for example, definitions like “brand name,” “common name,” and “drug identification number”).
• Changes definitions and labelling rules so prescription products that contain cannabis are identified by their brand and drug identification number.
• Creates a new role and rules for a “licensed dealer specialized in destruction” and clarifies who can witness and attest to the destruction of cannabis. Witness attestations must be kept for 2 years.
• Allows an individual who lawfully obtained cannabis to hand it to a pharmacist (outside hospitals) so the pharmacist can arrange for its destruction; cannabis given to a pharmacist for destruction is treated like a controlled substance for that purpose.
• Tightens or clarifies record‑keeping across pharmacies, hospitals, licensed dealers and practitioners (e.g., tracking brand name, DIN, quantity, strength).
• Updates rules for pharmacists and hospitals about selling, distributing and documenting prescription drugs that contain cannabis.
• Adds rules for “test kits” that contain cannabis: such kits must be registered for specific uses (medical, lab, industrial, education, law enforcement, research), and the government can refuse registration if the kit contains too much cannabis or if the kit’s denaturing agent would not stop someone from consuming the cannabis.
• Lets travellers import or export a drug containing cannabis if it is declared, properly labelled and does not exceed a 90‑day supply.
• Replaces several places where “statement” or “written statement” is used with the term “attestation” and makes small French wording adjustments.

Who's affected#

• Licensed cannabis producers and licensed dealers, including those who handle destruction.
• Pharmacists and hospitals that store, distribute or destroy prescription drugs containing cannabis.
• Medical practitioners who prescribe or handle cannabis drugs.
• People who possess cannabis and want to return it for destruction or who transport prescribed cannabis when entering or leaving Canada (travellers).
• Makers and assemblers of cannabis test kits, and labs or organizations that use them.
• Master growers and people in charge of cultivation who must meet knowledge requirements.
• Enforcement and regulatory staff who track records and witness destructions.

If it isn’t clear from the text who is affected by a particular change, the regulations themselves would provide the legal detail.

Why it matters#

• The changes reduce confusion between two sets of federal rules by using the same terms and processes for drugs that contain cannabis. That can make compliance simpler for companies and health-care providers.
• Better labelling (brand name and drug identification number) and clearer record‑keeping aim to make it easier to track legal medical cannabis products and reduce the risk of diversion into the illegal market.
• New, formalized ways to destroy unwanted cannabis (including using pharmacists and specialized licensed dealers) give people and institutions safer and clearer options for disposal.
• Test‑kit rules try to balance legitimate needs (research, lab testing, policing) with public‑safety concerns about kits that could be consumed or diverted.
• Traveller rules clarify how much prescribed cannabis someone can legally bring into or take out of Canada (up to a 90‑day supply, with required labels and declaration).